2001
DOI: 10.1046/j.1440-1789.2001.00365.x
|View full text |Cite
|
Sign up to set email alerts
|

Acute focal demyelinating disease simulating brain tumors: Histopathologic guidelines for an accurate diagnosis

Abstract: The object of the present study was to determine the histopathological guidelines for accurate diagnosis of cases of acute focal demyelinating disease that simulates brain tumors. The surgical pathology of three such cases is assessed. Histopathological keys to the diagnosis of such cases are as follows. First, a pattern of sheets of atypical gemistocytic astrocytes in the white matter that show well-formed processes and that are adequately distanced from each other argues against a diagnosis of neoplasm. Seco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
28
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(29 citation statements)
references
References 21 publications
1
28
0
Order By: Relevance
“…Using PCT, TDLs showed significantly lower BF, BV, and PS than HGGs [27]. These results are consistent with the observations that TDLs are characterized by normal or inflamed vessels and a lack of vascular proliferation while the latter is common in HGGs [26]. Primary brain lymphomas, brain metastases, and HGGs are malignant lesions that can appear similar to each other on MR images.…”
Section: Differentiation Of High-grade Gliomas From Other Brain Lesionssupporting
confidence: 87%
See 1 more Smart Citation
“…Using PCT, TDLs showed significantly lower BF, BV, and PS than HGGs [27]. These results are consistent with the observations that TDLs are characterized by normal or inflamed vessels and a lack of vascular proliferation while the latter is common in HGGs [26]. Primary brain lymphomas, brain metastases, and HGGs are malignant lesions that can appear similar to each other on MR images.…”
Section: Differentiation Of High-grade Gliomas From Other Brain Lesionssupporting
confidence: 87%
“…Tumefactive demyelinating lesions (TDLs) are solitary lesions greater than 2 cm that mimic HGGs on contrast-enhanced MR images [25], and can also be confused with HGGs on histopathology [26]. Differentiation of TDLs from HGGs may avoid unnecessary biopsy and resection of viable brain tissue.…”
Section: Differentiation Of High-grade Gliomas From Other Brain Lesionsmentioning
confidence: 99%
“…The situation could be confounded by the fact that TDLs can occasionally simulate neoplasms on histopathologic examination. 36,37 This has mostly been attributed to limited tissue samples such as those obtained from stereotactic brain biopsy. Biopsy of the gliotic margin may be pathologically misinterpreted at the edge of a glioma, and biopsy of the center of a TDL lesion may lead to the erroneous diagnosis of an infarct or necrotic neoplasm.…”
Section: Differentiating Gliomas From Other Non-neoplastic Lesions Anmentioning
confidence: 99%
“…One of the important biologic differences between TDL and high-grade intracranial tumors is the presence of neoangiogenesis and vascular endothelial proliferation in the latter, whereas TDLs are characterized by intrinsically normal or inflamed vessels without evidence of neovascularity. 36,38,39 TDLs show lower PS and CBV compared with high-grade gliomas, and PCT can be used to differentiate the 2 entities (Fig 6). 40 Similarly, various vasculitis and angiopathies can rarely present as solitary or multiple masslike lesions, mimicking neoplasms on morphologic imaging.…”
Section: Differentiating Gliomas From Other Non-neoplastic Lesions Anmentioning
confidence: 99%
“…[6][7][8] On images, TIDD and high-grade gliomas can both show contrast enhancement, perilesional edema, varying degrees of mass effect and central necrosis. 9 Enhancement in TIDD cases is thought to correlate with the degree of macrophage infiltration and related blood-brain barrier breakdown, which is a relatively early histological finding in cases of acute lesions.…”
Section: Administration Of High-dose Intravenous Immunoglobulinmentioning
confidence: 99%